# Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients

> **NCT03490396** · PHASE4 · TERMINATED · sponsor: **Midatech Pharma US Inc.** · enrollment: 28 (actual)

## Conditions studied

- Oral Mucositis

## Interventions

- **DEVICE:** Gelclair
- **COMBINATION_PRODUCT:** First® Mouthwash BLM

## Key facts

- **NCT ID:** NCT03490396
- **Lead sponsor:** Midatech Pharma US Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-15
- **Primary completion:** 2019-11-15
- **Final completion:** 2019-11-15
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** low recruitment
- **Last updated:** 2019-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03490396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03490396, "Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03490396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
